Furthermore, Xu et al.’s study (22) identified IFITM1, IFITM2, and IFITM3 as immune-related differentially expressed genes in DCM, implying that their aberrant expression may contribute to myocardial dysfunction through dysregulated immune-inflammatory pathways. Here, IFITM3 is linked to familial dilated cardiomyopathy.